Association between 9p21–23 Locus and Frailty in a Community-Dwelling Greek Population: Results from the Hellenic Longitudinal Investigation of Ageing and Diet - 21/11/24

Doi : 10.14283/jpad.2022.2 
N. Mourtzi 1, A. Hatzimanolis 2, 3, G. Xiromerisiou 4, E. Ntanasi 1, 5, M.K. Georgakis 6, 7, A. Ramirez 8, 9, 10, 11, S. Heilmann-Heimbach 12, B. Grenier-Boley 13, J.C. Lambert 13, M. Yannakoulia 5, M. Kosmidis 14, E. Dardiotis 4, G. Hadjigeorgiou 15, P. Sakka 16, Nikolaos Scarmeas 1, 17,
1 1st Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Vasilisis Sofias 72, Athens, Greece 
2 Department of Psychiatry, National and Kapodistrian University of Athens Medical School, Eginition Hospital, 11528, Athens, Greece 
3 Theodor-Theohari Cozzika Foundation, Neurobiology Research Institute, 11521, Athens, Greece 
4 Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece 
5 Department of Nutrition and Dietetics, Harokopio University, Athens, Greece 
6 Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-University, Munich, Germany 
7 Graduate School for Systemic Neurosciences, Ludwig Maximilians University, Munich, Germany 
8 Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, University of Cologne, Medical Faculty, Cologne, Germany 
9 Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany 
10 German Center for Neurodegenerative Diseases (DZNE Bonn), Bonn, Germany 
11 Department of Psychiatry and Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, San Antonio, TX, USA 
12 Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany 
13 Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE facteurs de risque et déterminants moléculaires des maladies liés au vieillissement, Lille, France 
14 Lab of Cognitive Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece 
15 Department of Neurology, Medical School, University of Cyprus, Nicosia, Cyprus 
16 Athens Association of Alzheimer’s Disease and Related Disorders, Marousi, Greece 
17 Department of Neurology, The Gertrude H. Sergievsky Center, Taub Institute for Research in Alzheimer’s Disease and the Aging Brain, Columbia University, New York, NY, USA 

r ns257@cumc.columbia.edu ns257@cumc.columbia.edu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Frailty is a complex geriatric syndrome arising from a combination of genetic and environmental factors and is associated with adverse health outcomes and mortality. A recent study reported an association between variants of the 9p21–23 locus, associated with a number of age-related disorders, including Alzheimer’s disease (AD), and frailty. Frailty has been associated with increased risk of developing AD and it has been proposed that frailty burden may modify AD clinical presentation. In view of the overlapping genetic architecture between the two disorders, it is noteworthy to conduct studies to uncover risk variants that contribute to both AD and frailty. The purpose of this study is to test the reproducibility of the association of 9p21–23 locus with frailty in a population that is ethnically different from previous work and in the context of multidimensional definitions of frailty that will allow us to examine the potential impact to domains pertaining to AD pathology.

Methods

We operationalized frailty according two definitions and the corresponding instruments, the Frailty Index (FI) and the Tilburg Frailty Indicator (TFI) and we determined genotypes of eight alleles previously identified as risk increasing for frailty in 1172 community-dwelling older participants (57% females) from the HELIAD study with a mean age of 74 years old. We cross-sectionally investigated the association between risk alleles and frailty, as well as with specific components of each definition using linear regression analyses adjusted for age, sex and years of education.

Results

Compared to non-carriers, carriers of rs7038172 C risk allele, were associated with a higher FI Score (β=0.089, p=0.002). Similarly, we found a positive association between the presence of at least one rs7038172 C variant and TFI score (β=0.053, p=0.04). Moreover, the rs7038172 variant was associated, irrespectively of dementia status, with the memory and psychological domain of FI and TFI, respectively.

Conclusion

Our study confirms the association of the rs7038172 C allele with the frailty syndrome in a Greek population and in the context of multidimensional definitions of frailty. Furthermore, we report novel associations between this allele and the memory domain of FI and the psychological domain of TFI, that includes memory problems on its components. Given that frailty burden has been shown to modify the AD clinical presentation, it is likely that rs7038172 C allele may accelerate the transition of AD or frailty to dementia Overall, our study corroborates the role of the 9p21–23 region in frailty development and draw potential links with AD pathology.

Le texte complet de cet article est disponible en PDF.

Key words : Frailty, 9p21–23 locus, Alzheimer, genetics


Plan


 Institutional Review Board Statement: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Boards of the University of Thessaly, Larisa, Greece, and the National and Kapodistrian University of Athens, Greece, Ethics Committees.


© 2022  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 9 - N° 1

P. 77-85 - janvier 2022 Retour au numéro
Article précédent Article précédent
  • At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer’s Disease and Related Research
  • J. Ford, D. Kafetsouli, H. Wilson, C. Udeh-Momoh, M. Politis, S. AhmadiAbhari, I. Rabiner, Lefkos T. Middleton
| Article suivant Article suivant
  • Associations of Cardiovascular and Non-Cardiovascular Comorbidities with Dementia Risk in Patients with Diabetes: Results from a Large UK Cohort Study
  • B. Zheng, B. Su, C. Udeh-Momoh, G. Price, I. Tzoulaki, E.P. Vamos, A. Majeed, E. Riboli, S. Ahmadi-Abhari, Lefkos T. Middleton

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.